Blockchain Registration Transaction Record

Garlic Variety Breakthrough: Antiviral Studies Support New Products at Gilroy Festival

Nick Diamantopoulos unveils new garlic products at Gilroy Garlic Festival backed by peer-reviewed studies showing specific cultivars inhibit SARS-CoV-2 and Influenza A. SupaG Health leads cultivar-specific antiviral garlic supplements.

This research matters because it challenges the notion that all garlic provides the same health benefits, potentially transforming the nutraceutical industry by offering cultivar-specific, evidence-based formulations. For consumers, it means future garlic supplements could be more effective against viruses like COVID and influenza, backed by science rather than tradition. For the garlic industry, it opens new commercial opportunities in premium health products, moving from generic commodities to targeted functional foods. However, readers should note that the studies are in vitro, not clinical, and products are not intended to treat or prevent disease.